Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: MAPP BIOPHARMACEUTICAL, INC.
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2020-09-30 to 2024-12-31
Current total value of award: $16303707
Description: THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE AND FULLY FUND OPTION 3 CLIN0004, UPDATE SOW, PROVIDE ADDITIONAL FUNDING FOR CLIN0001, ESTABLISH OPTION 4 CLIN0005, AND EXTEND THE PERIOD OF PERFORMANCE (POP) FOR CLIN0001